Literature DB >> 20396537

Cyclooxygenase-2: a potential target in human cancer.

Jong-Ho Won.   

Abstract

Entities:  

Year:  2004        PMID： 20396537      PMCID： PMC2855087          DOI： 10.4143/crt.2004.36.3.161

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN： 1598-2998            Impact factor:   4.679


× No keyword cloud information.
  14 in total

Review 1.  COX-2 inhibitors in oncology.

Authors:  Daniel G Haller
Journal:  Semin Oncol       Date:  2003-08       Impact factor: 4.929

Review 2.  Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

Authors:  A J Dannenberg; N K Altorki; J O Boyle; C Dang; L R Howe; B B Weksler; K Subbaramaiah
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

Review 3.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

Authors:  Michael J Thun; S Jane Henley; Carlo Patrono
Journal:  J Natl Cancer Inst       Date:  2002-02-20       Impact factor: 13.506

4.  Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA.

Authors:  H Sheng; J Shao; D A Dixon; C S Williams; S M Prescott; R N DuBois; R D Beauchamp
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

Review 5.  Celecoxib: a specific COX-2 inhibitor with anticancer properties.

Authors:  Alane T Koki; Jaime L Masferrer
Journal:  Cancer Control       Date:  2002 Mar-Apr       Impact factor: 3.302

6.  Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.

Authors:  Kathleen M Leahy; Richard L Ornberg; Yu Wang; Ben S Zweifel; Alane T Koki; Jaime L Masferrer
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

Review 7.  Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?

Authors:  Giampietro Gasparini; Raffaele Longo; Roberta Sarmiento; Alessandro Morabito
Journal:  Lancet Oncol       Date:  2003-10       Impact factor: 41.316

Review 8.  A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

Authors:  Louise R Howe; Andrew J Dannenberg
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

9.  Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts.

Authors:  A Diaz; K P Chepenik; J H Korn; A M Reginato; S A Jimenez
Journal:  Exp Cell Res       Date:  1998-05-25       Impact factor: 3.905

Review 10.  Prognostic impact of cyclooxygenase-2 in breast cancer.

Authors:  Carsten Denkert; Klaus-Jürgen Winzer; Steffen Hauptmann
Journal:  Clin Breast Cancer       Date:  2004-02       Impact factor: 3.225
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.